Press Releases

Emergent BioSolutions Receives Loan Repayment from Protein Sciences Corporation

...

Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals

...

Emergent BioSolutions to Release Third Quarter 2010 Financial Results and Conduct a Conference Call on November 4, 2010

...

Emergent BioSolutions Launches Singapore Operations

...

Emergent BioSolutions Receives Fast Track Designation for Its Investigational Monoclonal Antibody for the Treatment of Inhalational Anthrax

...

Emergent BioSolutions to Participate in October 2010 Investor Conferences

...

Emergent BioSolutions Awarded HHS Contract Valued at up to $186.6 Million to Develop rPA Anthrax Vaccine

...

Emergent BioSolutions Announces Early Termination of HSR Waiting Period for Its Acquisition of Trubion Pharmaceuticals

...

Emergent BioSolutions Announces Commencement of Phase I Clinical Trial for Monoclonal Antibody to Treat Inhalational Anthrax

...

Emergent BioSolutions Awarded NIAID Contract That Increases Potential Funding to Over $58 Million for Advanced Development of Third Generation Anthrax Vaccine

...

Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars

...

Emergent BioSolutions Announces Appointment of John E. Niederhuber, M.D. to the Company’s Board of Directors

...